Form 4 for SRTA Strata Critical Medical, Inc.
Accepted 2022-05-19 00:00:00 ET · period of report 2022-05-18 · accession 0001779128-22-000055 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-05-19 | 2022-05-18 | SRTA | Affeldt Eric | Dir | A - Grant | $0.00 | +11.4K | 671.7K | +2% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A common stock, $0.0001 par value per share | 2022-05-18 | A | A | 11,404 | $0.00 | 671,676 | D | — | — | (F1) Represents a grant of Restricted Stock Units ("RSUs"), which will be settled in shares of the Issuer's common stock upon vesting: 25% of the RSUs (rounded down to the nearest whole number) to become vested every three months measured from May 7, 2022, with the remainder to become vested on May 7, 2023, such that the RSUs become 100% vested on May 7, 2023. |